<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03243292</url>
  </required_header>
  <id_info>
    <org_study_id>92115848</org_study_id>
    <nct_id>NCT03243292</nct_id>
  </id_info>
  <brief_title>Bronchial Thermoplasty 10+ Year Study</brief_title>
  <official_title>Ten Year Follow-up of Subjects From 3 Landmark Randomized Controlled Bronchial Thermoplasty (BT) Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To confirm the long-term efficacy and safety of Bronchial Thermoplasty (BT) at 10 years
      follow-up or beyond in subjects previously enrolled in any of the following Boston
      Scientific-sponsored, controlled pre-approval studies: AIR, RISA and AIR2.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety Endpoint</measure>
    <time_frame>1 visit within 30 days of enrollment</time_frame>
    <description>Absence of bronchiectasis or bronchial stenosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Effectiveness Endpoint</measure>
    <time_frame>1 visit within 30 days of enrollment</time_frame>
    <description>Number of subjects who experience severe asthma exacerbations during the first and fifth years after treatment with the proportion of subjects who experience severe asthma exacerbations 12 months prior to enrollment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe asthma exacerbation rates exacerbations</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe asthma exacerbation rates subject</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe asthma exacerbation rates year</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of emergency room visits for respiratory adverse events</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of subjects with emergency room visits for respiratory adverse events</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of hospitalizations for respiratory adverse events</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with hospitalizations for respiratory adverse events</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of Respiratory Serious Adverse Events (SAEs)</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with respiratory SAEs)</measure>
    <time_frame>One day visit</time_frame>
    <description>evaluated for the 12 month period prior to the BT 10+ study visit and will be compared to the first and fifth years after BT treatment:</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">196</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Treated</arm_group_label>
    <description>Subjects that received Bronchial Thermoplasty in a prior study (AIR, RISA, or AIR2)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Subjects that participated in prior study (AIR) or (RISA) but did not receive Bronchial Thermoplasty Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <description>Subjects that participated in the AIR2 study, were blinded and did not receive the treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bronchial Thermoplasty</intervention_name>
    <description>patients had radio frequency ablation of the smooth muscle for asthma</description>
    <arm_group_label>Treated</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects that participated in one one or more of the prior studies (AIR, RISA, or AIR2)
        will be invited to participate in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Subjects previously enrolled in AIR, RISA or AIR2

          -  Subjects who received active BT treatment and had last BT treatment at least 10 years
             and 6 weeks prior to enrollment

          -  Control/Sham subjects with at least 10 years of long-term follow-up from index date
             plus 6 weeks

          -  Subject is able to read, understand and sign a written Informed Consent to participate
             in the Study and able to comply with the study requirements

        Exclusion Criteria:

          -  Severe asthma exacerbation or chest infection in the past 4 weeks. Subject entry into
             this study should be delayed until free from severe asthma exacerbation or chest
             infection for a minimum of 4 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frances Nolan, BSN</last_name>
    <phone>216-233-4467</phone>
    <email>frances.nolan@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth Kennedy</last_name>
    <phone>508-683-4807</phone>
    <email>elizabeth.kennedy@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Douglas Hogarth, MD</last_name>
      <phone>703-702-4773</phone>
      <email>dhogarth@uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elliot Israel, MD</last_name>
      <phone>617-732-8110</phone>
      <email>eisrael@partners.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202-268</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Simoff, MD</last_name>
      <phone>313-916-4406</phone>
      <email>msimoff1@hfhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regions Hospital Health Partners Specialty Center</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlene McEvoy, MD</last_name>
      <phone>651-254-7670</phone>
      <email>charlene.e.mcevoy@healthpartners.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110-1093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kaharu Sumino, MD</last_name>
      <phone>314-362-3010</phone>
      <email>ksumino@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Associates of Northern Virginia</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Duhamel, MD</last_name>
      <phone>703-521-6662</phone>
      <phone_ext>115</phone_ext>
      <email>duhamel@pmaofnova.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Derek Holmes, MD</last_name>
      <phone>+61 0 8-8222 4244</phone>
      <email>mark.holmes@sa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imandade Santa Casa de Misercordia</name>
      <address>
        <city>Pôrto Alegre</city>
        <state>RS</state>
        <zip>90035074</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adalberto Sperb Rubin, MD</last_name>
      <phone>5551-3286-7499</phone>
      <email>arubin@terra.com.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculdade da Medicina do ABC</name>
      <address>
        <city>Santo André</city>
        <state>Sao Paulo</state>
        <zip>09060-650</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gente Clube de Vida Promoção E Serviços 9 Centro de Pesquisa Maimônides</name>
      <address>
        <city>Pôrto Alegre</city>
        <zip>90480-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jussara Fiterman, MD</last_name>
      <phone>+55 51 999990231</phone>
      <email>fiterman@pucrs.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gerard Cox, MD</last_name>
      <phone>905-522-1155</phone>
      <phone_ext>5039</phone_ext>
      <email>coxp@mcmaster.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montreal Chest Institute</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronald Olivenstein, MD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>32114</phone_ext>
      <email>ronald.olivenstein@mcgill.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute Universitaire de Cardiologie et Pneumologie de Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louis Philippe Boulet, MD</last_name>
      <phone>418-656-4747</phone>
      <email>lpboulet@med.ulaval.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicholas ten Hacken, MD</last_name>
      <phone>31503 616161</phone>
      <email>n.h.t.ten.hacken@ubcg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital</name>
      <address>
        <city>Chelsea</city>
        <state>London</state>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pallav Shah, MD</last_name>
      <phone>02033158063</phone>
      <email>pallav.shah@ic.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gartnavel General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G12 OYN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rekha Chaudhuri, MD</last_name>
      <phone>01412110095</phone>
      <email>rekha.chaudhuri@ggc.scot.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Leicester Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE5 4PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Salman Siddiqui, MD</last_name>
      <phone>01162502873</phone>
      <email>ss338@leicester.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital, University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Niven, MD</last_name>
      <phone>0044401612915050</phone>
      <email>robert.niven@uhsm.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2017</study_first_submitted>
  <study_first_submitted_qc>August 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2017</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchial Thermoplasty</keyword>
  <keyword>Alair</keyword>
  <keyword>Registry</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

